Yan Wu

peking union medical college

H指数:29

被引数:3,956

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Display of CCL21 on cancer cell membrane through genetic modification using a pH low insertion peptide

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2023-06-014

PRE

Self-assembled nanocomposites of carboxymethyl β-dextran/protamine sulfate for enhanced chemotherapeutic drug sensitivity of triple-negative breast cancer by autophagy inhibition via a ternary collaborative strategy

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2023-04-019

PRE

Preparation of inhalable quercetin-B-cyclodextrin inclusion complexes using the supercritical antisolvent process for the prevention of smoke inhalation-induced acute lung injury

JOURNAL OF CO2 UTILIZATION

IF8.4

2023-03-019

OAAI

Impact of obstructive sleep apnea on aortic disease occurrence: A meta-analysis

HELIYON

IF3.6

2022-08-013

OAAI

Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma

靶向腺苷酸通路增强索拉非尼抗肝癌疗效的研究

HEPATOLOGY INTERNATIONAL

IF6.1

2019-12-0421

PREAI

Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's Disease

JOURNAL OF CROHNS & COLITIS

IF8.7

2019-11-0618

OAAI

Protective effects of coffee consumption following liver transplantation for hepatocellular carcinoma in cirrhosis

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2019-02-2717

OAAI

Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression

BMC CANCER

IF3.4

2018-07-2844

OAAI

Novel cell-based high-throughput hybridoma screening method using the Celigo image cytometer for antibody discovery

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma

NATURE COMMUNICATIONS

IF15.7

2018-03-0176

OAAI

Central nervous system progression in advanced non-small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study

EGFR突变的晚期非小细胞肺癌患者对两种egfr-tki，吉非替尼和厄洛替尼一线治疗的中枢神经系统进展: 一项比较研究

BMC CANCER

IF3.4

2017-04-0425

OAAI

INHIBITION OF P-GLYCOPROTEIN/MDR1 TRANSPORTER SUPPRESSES TH17 EFFECTOR FUNCTION IN INFLAMMATORY BOWEL DISEASE

GASTROENTEROLOGY

IF25.1

2017-04-010

PREAI

Distinct hepatitis B virus integration patterns in hepatocellular carcinoma and adjacent normal liver tissue

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-01-2719

OAAI

Novel anti-PD-L1/IL-15 bifunctional immunotherapeutics potentiates antitumor immunity

CANCER RESEARCH

IF16.6

2016-07-150

PRE

A novel anti-PDL1 x anti-VEGFR2 bispecific antibody for enhanced antitumor immunity

CANCER RESEARCH

IF16.6

2016-07-150

PRE

NADH oxidase-dependent CD39 expression by CD8+ T cells modulates interferon gamma responses via generation of adenosine

NATURE COMMUNICATIONS

IF15.7

2015-11-0968

OAAI

Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α

AHR和HIF1-α 对1型调节性T细胞分化的代谢控制

NATURE MEDICINE

IF50

2015-05-25385

OAAI

Sublethal Heat Treatment Promotes Epithelial-Mesenchymal Transition and Enhances the Malignant Potential of Hepatocellular Carcinoma

亚致死性热处理促进上皮-间质转化并增强肝细胞癌的恶性潜能

HEPATOLOGY

IF15.8

2013-11-01128

Vascular CD39/ENTPD1 Directly Promotes Tumor Cell Growth by Scavenging Extracellular Adenosine Triphosphate

NEOPLASIA

IF7.7

2011-03-01127

OAAI

CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice

CD4 Foxp3调节性T细胞表达CD39/ENTPD1促进小鼠肝转移瘤生长

GASTROENTEROLOGY

IF25.1

2010-09-01255

Yan Wu

个人简介

教育背景

工作经历

荣誉奖项

研究方向